Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC – Get Free Report) CEO Albert Cha bought 300,000 shares of the business’s stock in a transaction dated Thursday, October 15th. The shares were bought at an average price of $10.00 per share, with a total value of $3,000,000.00. Following the purchase, the chief executive officer owned 300,000 shares in the company, valued at $3,000,000. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Frazier Life Sciences Acquisition Corp. II Price Performance
Shares of NASDAQ FLSC opened at $10.35 on Friday. Frazier Life Sciences Acquisition Corp. II has a one year low of $10.18 and a one year high of $10.59.
About Frazier Life Sciences Acquisition Corp. II
Frazier Life Sciences Acquisition Corp. II is a special purpose acquisition company, or SPAC, focused on identifying and combining with a business in the life sciences sector. The company does not operate a conventional commercial business and was formed to pursue a merger, acquisition, or similar business combination.
Its target opportunities may include companies involved in biotechnology, pharmaceuticals, medical devices, diagnostics, or other healthcare-related technologies. The company’s objective is to provide a publicly traded platform for a private life sciences business through a business combination.
Frazier Life Sciences Acquisition Corp.
Read More
- Five stocks we like better than Frazier Life Sciences Acquisition Corp. II
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Frazier Life Sciences Acquisition Corp. II Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Frazier Life Sciences Acquisition Corp. II and related companies with MarketBeat.com's FREE daily email newsletter.
